1. Home
  2. EXPO vs ACLX Comparison

EXPO vs ACLX Comparison

Compare EXPO & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$67.30

Market Cap

3.4B

ML Signal

HOLD

Logo Arcellx Inc.

ACLX

Arcellx Inc.

HOLD

Current Price

$114.38

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
ACLX
Founded
1967
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
EXPO
ACLX
Price
$67.30
$114.38
Analyst Decision
Buy
Hold
Analyst Count
3
15
Target Price
$90.50
$115.85
AVG Volume (30 Days)
461.8K
3.6M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.78%
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$582,014,000.00
$22,286,000.00
Revenue This Year
$12.61
$329.40
Revenue Next Year
$8.00
$151.37
P/E Ratio
$33.60
N/A
Revenue Growth
4.21
N/A
52 Week Low
$63.81
$47.86
52 Week High
$84.00
$114.80

Technical Indicators

Market Signals
Indicator
EXPO
ACLX
Relative Strength Index (RSI) 37.93 83.30
Support Level $64.70 $66.06
Resistance Level $73.22 $114.80
Average True Range (ATR) 2.21 0.35
MACD -0.36 -0.30
Stochastic Oscillator 9.87 65.68

Price Performance

Historical Comparison
EXPO
ACLX

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About ACLX Arcellx Inc.

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Share on Social Networks: